re: Ann: Mesoblast, Intrexon and Ziopharm to ... Let's be honest, there's been a whole heap of incremental positives but until MSB has one of its applications approved in this groundbreaking category there will be a ceiling on the SP!
Stick to trading it through the sub 5.50-6 range or averaging down if that's your shtick...as this isn't going anywhere until there's some real progress in trials and FDA approval.
Ann: Mesoblast, Intrexon and Ziopharm to Target C, page-5
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |